Skip to main content
PolicySpeak
← All files
LAB

Labcorp

Company · United States · EU Transparency Register 878238423039-24

2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #544 by legislative files engaged — a count of participation, not a measure of influence.

1.5
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2016
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Registered as
Laboratory Corporation of America Holdings (Labcorp)
Head office
Burlington, United states
EU office
Mechelen

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Labcorp in PolicySpeak: request access →

Work at Labcorp? so we know who speaks for it.

Follow the file Labcorp engages with

One email on Tuesdays when a new position is filed on this file, from Labcorp or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Labcorp filed 2 positions between 6 Oct 2025 and 9 Apr 2026, across 1 of the 326 legislative files tracked here.

2025 · 1 filed2026 · 1 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 9 Apr 2026source

Labcorp is a global leader in innovative laboratory services and the market leader in central laboratory services (CLS) supporting EU-based clinical trials through t testing samples from EU patients. Biotech and pharma rely on CLS to provide the highest level of global data consistency, crucial to multinational clinical trials Labcorp welcomes the Commissions proposal to streamline and simplify the MDR and IVDR…

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025source

Labcorp is a global leader in innovative laboratory services and the market leader in central laboratory (CL) testing services. We have a strong R&D footprint in Europe, and our CL in Switzerland analyses samples from clinical trial patients in EMEA. A CL is a laboratory where specimen samples from clinical trial patients are analysed to guide decisions on clinical trials and patient management.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Labcorp’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.